Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Bright Minds Biosciences Inc. (DRUG) had Return on Investments of -14.90% for the most recently reported fiscal year, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.74M |
|
-- |
|
-- |
|
$9.96M |
|
$-9.96M |
|
$1.22M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-8.74M |
|
$-9.96M |
|
$-9.91M |
|
6.88M |
|
6.88M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$60.27M |
|
-- |
|
$0.08M |
|
$60.35M |
|
$1.67M |
|
$0.03M |
|
$0.03M |
|
$1.70M |
|
$58.65M |
|
$58.65M |
|
$58.65M |
|
7.64M |
|
| Cash Flow Statement Financials | |
$-6.21M |
|
-- |
|
$61.17M |
|
$4.09M |
|
$59.27M |
|
$55.18M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
36.10 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.91% |
|
-14.91% |
|
-14.49% |
|
|
Return on Investments |
-14.90% |
$7.68 |
|
$-0.90 |
|
$-0.90 |
|